ALC
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Alcidion Group Limited is a healthcare technology company that develops, licenses, and supports digital health software solutions for healthcare organizations in Australia, New Zealand, and the United Kingdom. The company’s flagship platform, Miya Precision, aggregates data from multiple clinical and operational systems to deliver real-time information for clinical decision-making, patient flow, and workflow management. Key modules include electronic patient records, clinical workflow, electronic observations, task management, emergency department operations, and virtual care. The group also provides implementation, support, maintenance, systems integration, and data analytics services. Through the acquisition of Kyra flow products from Telstra Health, Alcidion expanded its patient flow capabilities. The company serves hospitals and healthcare organizations across its core markets, with customers including North Cumbria Integrated Care NHS Foundation Trust, Hywel Dda University Health Board, Leidos Australia, and University Hospitals Sussex NHS Foundation Trust. Alcidion was founded in 2000 and listed on the Australian Securities Exchange in 2016. It has acquired several healthcare IT companies, including Oncall Systems (provider of Smartpage), MKM Health, Patientrack, ExtraMed Ltd, and Silverlink Software, which were integrated under the Alcidion brand in 2019.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Health Care Equipment & Services Homepage alcidion.com
Sector Healthcare IR page alcidion.com/investor-centre
Tags
electronic patient records, clinical workflow, patient flow, virtual care, remote patient monitoring, clinical decision support, health informatics, fhir interoperability, task management, emergency department operations, Miya Precision, Smartpage, Patientrack, Kyra, Oncall Systems, MKM Health, ExtraMed Ltd, Silverlink Software, Miya Scribe, Miya Insight, Miya Virtual Care
Press page alcidion.com/news

Metrics

Valuation  
Market cap A$ 155.228M
P/E 61.33
P/BV 1.54
P/S 3.01
P/OCF 22.67
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 2.6%
ROI 2.5%
ROIC 2.5%
Profit margin 4.4%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 26.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2016 FY 2015
Revenue 51.641M 40.786M 37.057M 40.4M 34.355M 25.882M 18.608M 16.864M 3.15M 2.842M 4.843M
Net profit 2.285M 1.654M -8.417M -3.617M -4.412M -2.244M -3.077M -84.165K -2.089M — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2016 FY 2015
Share price 0.09 — — — — — — — — — —
P/E 54.71 — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

What’s new in Miya Precision 7.11.0? Bull 1 Bear 0 Product/operations

September 30, 2026 | Miya Precision

On this page

September 16, 2026

Getting EPR right isn’t just about the technology going live, it’s about the people who make it stick.

We’re proud to have contributed to a new white paper from the UK EPR Network, convened by the Healthcare Innovation Consortium, exploring what really drives successful digital transformation in the NHS. As EPR adoption grows across trusts, the challenge is shifting from implementation to optimisation, embedding these systems into everyday practice so they’re used consistently and deliver real improvements in care.

Alongside colleagues from CLEO Systems, Enovacom, First DataBank (FDB), Ready Computing and System C, and NHS partners, we shared our perspective on the vital role clinical champions and super users play in bridging the gap between deployment and lasting change.

In this report:

  • Why data quality is the foundation EPR success is built on

  • How better data capture leads to better clinical decisions and better care

  • Getting structure, automation and workflow design right from the start

  • Treating EPR migration as a chance to reset data quality, not carry it forward

  • Why governance, interoperability and clear ownership matter as much as the technology itself

  • Building trusted data foundations for analytics, AI and what comes next for the NHS

Prompts

Alcidion Group Limited (ticker ALC), listed in Australia.